Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1-Reference-Cited by-同舟云学术

Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1

Published:1999-06 Issue:25 Volume:18 Page:3742-3753
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Kortylewski Marcin,Heinrich Peter C,Mackiewicz Andrzej,Schniertshauer Ute,Klingmüller Ursula,Nakajima Koichi,Hirano Toshio,Horn Friedemann,Behrmann Iris

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1202708.pdf

Reference56 articles.

1. Arcone R, Pucci P, Zappacosta F, Fontaine V, Malorni A, Marino G and Ciliberto G. . 1991 Eur. J. Biochem. 198: 541–547.

2. Bellido T, O'Brien CA, Roberson PK and Manolagas SC. . 1998 J. Biol. Chem. 273: 21137–21144.

3. Boeuf H, Hauss C, De Graeve F, Baran N and Kedinger C. . 1997 J. Cell. Biol. 138: 1207–1217.

4. Boulton TG, Stahl N and Yancopoulos GD. . 1994 J. Biol. Chem. 269: 11648–11655.

5. Casagrande F, Bacqueville D, Pillaire MJ, Malecaze F, Manenti S, Breton-Douillon M and Darbon JM. . 1998 FEBS Lett. 422: 385–390.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis;Frontiers in Immunology;2023-11-01

2. The clinical relevance of OSM in inflammatory diseases: a comprehensive review;Frontiers in Immunology;2023-09-29

3. Variation in IL6ST cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cells;Cellular Signalling;2023-03

4. Association of oncostatin M receptor polymorphisms with clinical recurrence of ovarian cancer in the Chinese Han population;Biomarkers in Medicine;2022-04

5. Growth factors, cytokines, and pediatric malignant primary bones tumors;Bone Cancer;2022